ΤΑ ΝΕΑ ΤΗΣ ΕΛΕΚΖΣ

WSAVA - COVID 19 - Ενημέρωση 27 Οκτωβρίου 2020

Γράφτηκε από τον/την ΕΛ.Ε.Κ.Ζ.Σ. στις .

wsavalogo

 

COVID-19 - An update for WSAVA Members
October 27th, 2020

There have been a number of notable discussions recently concerning the role SARS-CoV-2 plays in the health of companion animals so we aim to bring WSAVA members up to date in this latest e-shot:

The use of SARS-CoV-2 assays

The use of antibody assays, antigen assays, nucleic acid amplification assays such as quantitative reverse transcriptase PCR assay (qRT-PCR), and virus isolation assays in the diagnosis and management of both human and animal cases with possible SARS-CoV-2 infection continues to generate discussion and, frequently, confusion.

We would like to share our thinking and highlight useful resources you can use to help answer questions your owners or staff may have for you. Key points to remember include:

Antibodies against SARS-CoV-2 prove that an animal or person was exposed to the virus and developed an immune response.

  • Positive antibody test results do not prove the presence of live virus in an individual.
  • By the time an individual has a positive antibody test result, it would be unlikely that they could be shedding live virus.
  • Work continues to determine what are the best viral targets to use in antibody tests and how best to use the results in management strategies in both humans and animals
  • The Center for Disease Control provides interim guidance for the use of antibody tests in humans and is a great source of information.

CDC's antibody test guidelines

Positive results in SARS-CoV-2 antigen assays, qRT-PCR assays, and virus isolation assays confirm the presence of the virus, but only virus isolation assays confirm the presence of living virus. Thus, a person or pet that is positive for SARS-CoV-2 antigens or RNA amplified by qRT-PCR assay may not be contagious.

People have now been shown to be positive for viral RNA by qRT-PCR assays for up to 12 weeks, long after they stopped being infectious to others. This is why the Center for Disease Control no longer recommends a test-based strategy for return-to-work plans for previously positive people.

CDC: return to work

A recently published study evaluated qRT-PCR assay, a virus isolation assay, and several different antibody assay results in experimentally infected adult dogs and adult cats and helps us understand more about what happens when an animal is infected with SARS-CoV-2 by contact with an infected person.

Study on infected adult dogs and cats

  • While dogs became transiently qRT-PCR assay positive and developed serum antibodies, clinical signs were not noted and live virus was not grown from any dog.
  • Primary inoculated cats passed live virus to other cats in direct contact, but none of the cats developed clinical signs of disease.
  • Viral RNA and live virus were detected transiently in the cats after primary inoculation or direct contact. However, the shedding was of short duration and was completed during the time periods generally recommended for quarantine in many countries (10-14 days after exposure or clinical signs)
  • Neutralizing antibody titers developed and cats that had a second challenge with the virus on Day 28 did not repeat shedding of live virus.

The results of this study of experiment animals supports observations from client-owned animals that suggest that infection of animals from people occurs (reverse zoonoses), but is uncommon and does not result in serious disease in most exposed animals. If you would like to evaluate the SARS-CoV-2 infected companion animals reported to date, please visit the OIE site below.

Visit the OIE website: Q&A on SARS-CoV-2

Companion animal research on SARS-CoV-2 using results from field cases continues in many countries. For example, the Center for Companion Animal Studies at Colorado State University has permission to use a research qRT-PCR assay to evaluate samples from dogs with unexplained causes of the Canine Infectious Respiratory Disease Complex in the United States. To date, dogs positive for SARS-CoV-2 have not been detected.

It has been great to have access to manuscripts in pre-review via portals such as www.biorxiv.org . However, the WSAVA One Health Committee reminds our members that these manuscripts have not completed peer-review and may be modified greatly before publication or not be accepted for publication.

The use of animals in animal-assisted therapy

We have received questions as to when restrictions on the use of companion animals in important health care services, such as animal-assisted therapy will be ended. This is an extremely important global One Health issue. Hopefully, as further information concerning SARS-CoV-2 shedding rates in dogs becomes more widely available, some countries will allow the lifting of restrictions. Please contact your local health authorities for advice about this issue in the interim period.

Latest webinar added to WSAVA COVID-19 resource hub

One of the most notable new additions to the WSAVA’s COVID-19 resource hub is a WSAVA One Health webinar entitled ‘The impact of COVID-19 on your patients and staff: An update.’ During the webinar, Peter Karczmar MD, Michael R. Lappin, DVM, and Richard Squires BVSc discussed a range of important updates concerning the risk of SARS-CoV-2 infections to your staff and the impact of COVID-19 on your patients and preventative health programs. Please enjoy the webinar if you missed the live recording and let us know at Αυτή η διεύθυνση ηλεκτρονικού ταχυδρομείου προστατεύεται από τους αυτοματισμούς αποστολέων ανεπιθύμητων μηνυμάτων. Χρειάζεται να ενεργοποιήσετε τη JavaScript για να μπορέσετε να τη δείτε. if you have comments to share. We thank MSD Animal Health for supporting the webinar.

We hope you find this e-shot useful and will be adding translations to the Resource Hub in the coming days.

Please let us know if you have questions or comments. Stay safe!

Michael R. Lappin, DVM, PhD, DACVIM (Internal Medicine) The Kenneth W. Smith
Professor in Small Animal Clinical Medicine, Colorado State University

Chairman, WSAVA One Health Committee

Professor Mary Marcondes, DVM, MSc, PhD
Professor (retired) of Small Animal Internal Medicine and Infectious Diseases - School of Veterinary Medicine, São Paulo State University, Brazil Co-chair of the WSAVA Scientific Committee

Visit the WSAVA COVID-19 resource hub here

 

 

WSAVA - COVID 19 - Ενημέρωση 25 Απριλίου 2020

Γράφτηκε από τον/την ΕΛ.Ε.Κ.Ζ.Σ. στις .

wsavalogo

 

COVID-19 - An update for WSAVA Members
April 25th, 2020

In the days since our last update on April 11, 2020, there have been many notable reports concerning SARS-CoV-2 and small companion animals. WSAVA was fortunate to have the support of the Purina Institute and Zoetis Inc. to host a webinar that covered most of the current issues at the time the webinar first aired on April 17. If you have not watched it yet, you can view it here:

View the webinar here

We will be adding translations of the content in several languages to the WSAVA’s COVID-19 resource hub over the next few days. It contains a wealth of resources on COVID-19 and companion animals to help you, with new content being added weekly so please check it regularly and urge your members to do the same.

Since the webinar, the interrelated topics that have generated the most discussion are:

  • how common are SARS-CoV-2 infections in naturally exposed dogs and cats?
  • how likely are these animals to develop clinical illness from this virus?
  • should the veterinary profession be performing wide-spread testing of dogs and cats to help to answer the first two questions?

Soon after our webinar, another serological survey paper was made available for outside review. In it, serological test results were reported for 35 species, including some dogs and cats. Data from Wuhan City, the presumed origin of the pandemic, showed that all of the 15 pet dogs, 99 street dogs, 66 pet cats, and 21 street cats were negative for antibodies against SARS-CoV-2.

Read the Paper here

Junhua Deng et al. SHORT COMMUNICATION Serological survey of SARS‐CoV‐2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals Transbound Emerg Dis 2020 Apr 17

This week, the first two cats in the United States to test positive for SARS-CoV-2 RNA by rtPCR assay were reported and the CDC and USDA’s National Veterinary Services Laboratories (NVSL) subsequently posted their findings and recommendations. The cats were initially identified by a commercial laboratory doing independent surveillance work using samples submitted for testing for other pathogens. These cats both had a mild respiratory illness are expected to make a full recovery. Public health and animal health officials are still learning about SARS-CoV-2, but there is no evidence that pets play a role in spreading the virus. Therefore, there is no justification in taking measures against companion animals that may compromise their welfare.

There is more information available here:

To date, several commercial laboratories conducting voluntary surveillance work and providing their results have reportedly tested more than 7,500 dogs and cats with only the two positive feline cases detected to date.

A novel approach to identifying trends in clinical illness in dogs and cats was recently reported by pet medical insurance provider, Trupanion. The company has data from millions of dog and cat insurance claims over 20 years. In a webinar posted on April 17th, Dr. Steve Weinrauch, BVMS, MRCVS, Chief Veterinary Officer, Trupanion showed that, since the start of the COVID-19 pandemic, respiratory claims have not seen an upward trend. Detailed analysis of claims data is a critical part of how Trupanion operates and has been consistently reviewed for decades. The company is committed to continuing with plans to alert the CDC if any regional trends are noted.

View the webinar here

As of April 23, 2020, WHO reports 2,626,321 confirmed COVID-19 cases in people while the total of confirmed cases of SARS-CoV-2 in dogs and cats stands at fewer than ten. The failure to detect more positive cases in dogs and cats is undoubtedly related in part to a lack of widespread testing in these species. However, based on the experimental and natural exposure information gathered to date, infection of dogs and cats is most likely associated with exposure to an infected human. It is difficult to infect dogs and cats with SARS-CoV-2, clinical illness is unlikely and self-limited when it occurs, and long-term shedding at levels likely to infect a new human has still not been documented. This means that the results of testing of individual animals is unlikely to be of clinical benefit. However, well-designed epidemiologic studies are needed to further define the role of cats and dogs in this pandemic.

Public health and animal health entities around the world continue to review the cumulative data on companion animals daily and to update recommendations frequently. For example, the new CDC guidelines for veterinarians were published on April 23, 2020 and will be updated frequently as new information is gathered. Please also refer to guidelines published in your countries.

Interim Infection Prevention and Control Guidance
for Veterinary Clinics During the COVID-19 Response

Information on keeping both people and animals safe and healthy is also available

We thank you too for all you are doing to continue to care for your patients and reassure their owners. Please keep yourselves and your families safe in these difficult times.

Michael R. Lappin, DVM, PhD, DACVIM (Internal Medicine) The Kenneth W. Smith
Professor in Small Animal Clinical Medicine, Colorado State University

Chairman, WSAVA One Health Committee

Visit the WSAVA COVID-19 resource hub here

 

 

WSAVA Free Webinar: COVID-19 and Companion Animals – What we know today

Γράφτηκε από τον/την ΕΛ.Ε.Κ.Ζ.Σ. στις .

wsavalogo

 

COVID-19 - An update for WSAVA Members
April 11th, 2020

WSAVA Webinar: COVID-19 and Companion Animals – What we know today
Friday April 17, 2020 14.00hrs GMT {10.00hrs (EST); 15.00hrs (London); 22.00hrs (Hong Kong)}

The Covid-19 pandemic is causing distress and uncertainty for us all. It also poses a significant and real threat to companion animal welfare, particularly given conflicting media reports on whether pets can spread the virus. As part of our effort to keep you up-to -date with the latest information on COVID-19, we are hosting an hour-long webinar next Friday April 17. The expert speakers are:

  • Dr Vanessa Barrs, Professor of Companion Animal Health, City University of Hong Kong
  • Dr Michael Lappin, Chair of the WSAVA One Health Committee
  • Dr Shane Ryan, WSAVA President

During the webinar they will address what the evidence actually tells us about COVID-19 and companion animals, as well as how to provide optimal preventative care for pets in the face of the pandemic. They will also discuss the important role that veterinarians can play in promoting pet welfare and supporting the human-companion animal bond during this difficult time.

We hope that the information our speakers will give you will help you to reassure your clients, your co-workers and your communities based on the latest evidence. We also hope our recommendations support you in continuing to provide the highest standard of care to your patients.

Join the webinar here

wsava webinar covid

We are grateful to WSAVA Diamond Partner the Purina Institute and WSAVA Industry Partner Zoetis for their generous support of this webinar.

We hope that you and many of your members will be able to join the webinar live so please share this information with them urgently. If you are unable to watch it live, you will also be able to watch it on demand when it is added to the WSAVA’s COVID-19 resource hub. We have again added new content this week, much of it available in a range of languages, for which we we extend our grateful thanks to the WSAVA One Health, Scientific and Translation Committees.

Visit the WSAVA COVID-19 resource hub here

Please keep yourselves and your families safe in these difficult times.

On behalf of the WSAVA Secretariat,

Emma van Rooijen
Executive Assistant

 

 

WSAVA - COVID 19 - Ενημέρωση 6 Απριλίου 2020

Γράφτηκε από τον/την ΕΛ.Ε.Κ.Ζ.Σ. στις .

wsavalogo

 

COVID-19 - An update for WSAVA Members
April 6th, 2020

We started this week with the news release by the Wildlife Conservation Society’s Bronx Zoo in New York, USA reporting a resident four-year old female Malayan tiger that has tested positive for SARS-CoV-2 after being presented with cough and decreased appetite. The positive SARS-CoV-2 test for the tiger was confirmed by the United States Department of Agriculture (USDA’s) National Veterinary Services Laboratory. The likely source of infection was a person caring for them who was asymptomatically infected with the virus. Although three other tigers and three African lions also had a dry cough, only one tiger was tested because of the risk associated with collecting samples under anesthesia. Though they have experienced some decrease in appetite, the tigers and lions are otherwise doing well under veterinary care and are bright, alert, and interactive with their keepers. The four affected tigers live with one Amur tiger that has not exhibited any clinical signs. Three other tigers from the same zoo, as well as snow leopards, cheetahs, clouded leopard, Amur leopard, puma or serval are not presenting any signs of illness.

Assuming the other three lions and tigers with signs were ill due to SARS-CoV-2, this may support the findings of a domestic cat experimental study we commented on in our e-shot of April 3. In this study, some cats inoculated with a high dose of SARX-CoV-2 developed clinical signs of disease and some were able to pass the virus to other animals housed in close proximity.

Further studies will be required to determine whether exotic cats are more susceptible to the SARS-CoV-2 virus than domestic cats.

Read the USDA's statement here

Another preprint study published since our last e-shot investigated the presence of antibodies to SARS-CoV-2 in cats from Wuhan. Results from samples from 102 cats collected during the COVID-19 outbreak (January to March 2020) were compared to those from 39 cats collected prior to the outbreak in 2019. Antibodies against SARS-CoV-2, were detected in 15 (14.7%) of the cat samples obtained after the outbreak in an experimental indirect enzyme linked immunosorbent assay (ELISA). Eleven of the 15 samples had antibodies detected by virus neutralization. SARS-CoV-2 RNA was not amplified by specific qRT-PCR from any of the cats assayed. The results of this study suggest that cats can be naturally exposed to SARS-CoV-2 and mount a serological response. Similar to previous reports of the cats quarantined in Hong Kong, shedding of virus in naturally exposed cats is either of short duration or of low levels.

We have been asked this week if and when countries will start suggesting testing clinically ill cats or any cat that was housed with a person known to have COVID-19 associated illness. The WSAVA does not currently have information from each country and recommendations or requirements are changing rapidly. We suggest contacting public health authorities for your region or country for this information. Comments from the USDA are included in the document cited above. The OIE and CDC websites are also excellent sources of updated internationally relevant information.

oie cdc
OIE Information on COVID-19 CDC Information on COVID-19

 

Others have questioned whether WSAVA will recommend ivermectin for the treatment or prevention of SARS-CoV-2 infection of companion animals based on another pre-print, in vitro manuscript that was just made available. At this time, there is not enough information to make recommendations of how to use this information in clinical practice. To date, illness in dogs or cats potentially related to SARS-CoV-2 from natural infection has been non-existent or apparently self-limited.

Read the following article for more information:
"The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro"

The WSAVA One Health and Scientific Advisory Committees emphasize that pet owners sick with COVID-19 should avoid direct contact with animals in their household, including petting, snuggling, being kissed or licked, and sharing food. If they need to care for their pet or be around animals while they are sick, they should wash their hands before and after they interact with them and wear a facemask.

Again, we’d like to end by reminding you that, if you haven’t checked it for a few days, please re-visit the WSAVA’s COVID-19 resource hub as we are adding further content regularly.

Visit the WSAVA COVID-19 resource hub here

Please keep yourselves and your families safe in these difficult times.

Michael R. Lappin, DVM, PhD, DACVIM (Internal Medicine) The Kenneth W. Smith
Professor in Small Animal Clinical Medicine, Colorado State University

Chairman, WSAVA One Health Committee

Professor Mary Marcondes, DVM, MSc, PhD
Professor (retired) of Small Animal Internal Medicine and Infectious Diseases - School of Veterinary Medicine, São Paulo State University, Brazil Co-chair of the WSAVA Scientific Committee

 

 

WSAVA - COVID 19 - Ενημέρωση 3 Απριλίου 2020

Γράφτηκε από τον/την ΕΛ.Ε.Κ.Ζ.Σ. στις .

wsavalogo

Ενημέρωση Μελών Παγκόσμιας Κτηνιατρικής Εταιρείας Μικρών Ζώων (WSAVA)
Για την εβδομάδα που ολοκληρώθηκε στις 3 Απριλίου 2020

(original article... here)

Η τελευταία ενημέρωσή μας για τη νόσο COVID-19 στις 27 Μαρτίου τελείωνε με αναφορά σε μία γάτα στο Βέλγιο, η οποία αναφέρθηκε ότι ήταν θετική με RT-PCR και κλινικά ασθενής.

Μετά την προ-δημοσίευση μιας εργασίας που, με βάση τη δέσμευση υποδοχέων invitro, έδειχνε ότι οι γάτες και οι νυφίτσες μπορεί θεωρητικά να είναι ευπαθείς στη μόλυνση με τον ιό SARS-CoV-2, ανακοινώθηκε (18/03) περίπτωση γάτας με φυσική έκθεση στη νόσο, στο Βέλγιο. Η γάτα ζούσε με ένα μέλος οικογένειας με COVID-19, διαπιστώθηκε με PCR ότι ήταν θετική στον ιό SARS-CoV-2και εμφάνιζε συμπτώματα παροδικού εμέτου, διάρροια και αναπνευστική νόσο. Η γάτα ανέρρωσε χωρίς προβλήματα και ο έλεγχός της συνεχίζεται για να διαπιστωθεί αν θα αναπτύξει αντισώματα έναντι του ιού. Δεν είναι δυνατόν να καθοριστεί με βεβαιότητα ότι η γάτα αυτή νοσούσε λόγω προσβολής της από τον ιό SARS-CoV-2.

Δεδομένα από πειραματική μόλυνση με SARS-CoV-2 σε γάτες, νυφίτσες και άλλα είδη άρχισαν να εμφανίζονται στη βιβλιογραφία και μια προ-δημοσίευση ενός πειραματικού μοντέλου SARS-CoV-2 που βρίσκεται προς το παρόν υπό κρίση, πριν γίνει δεκτή για δημοσίευση, συζητείται ευρέως στα ΜΜΕ. Στην εργασία αυτή, η μόλυνση με SARS-CoV-2 σε συγκεκριμένα είδη ζώων έγινε με ενοφθαλμισμό μεγάλης δόσης ιού και μερικά από τα ζώα που μολύνθηκαν πρωτογενώς με αυτόν τον τρόπο, μεταξύ αυτών και οι γάτες, μπορούσαν να μεταφέρουν τον ιό σε άλλα ζώα που διατηρούνταν σε κοντινή απόσταση. Κλινικά συμπτώματα νόσου αναγνωρίστηκαν σε μερικά από τα ζώα.

Μελέτες αυτού του τύπου μας βοηθούν να αντιληφθούμε το εύρος των ξενιστών του COVID-19, την παθογένειά του και να αναπτύξουμε νέα μοντέλα θεραπείας και πρόληψης. Ωστόσο, η Επιτροπή Ενιαίας Υγείας και η Συμβουλευτική Επιστημονική Επιτροπή της Παγκόσμιας Κτηνιατρικής Εταιρείας Μικρών Ζώων τονίζουν με έμφαση ότι μελέτες αυτού του τύπου δεν μπορούν να συσχετιστούν άμεσα με ό,τι συμβαίνει στην πράξη. Και το σπουδαιότερο, δεν γνωρίζουμε ακόμη εάν οι υψηλές δόσεις του SARS-CoV-2 που χορηγήθηκαν για την πρωτογενή πειραματική μόλυνση σε γάτες, νυφίτσες και σκύλους θα μπορούσαν να συγκριθούν με εκείνες στο φυσικό περιβάλλον, όπου ένας ιδιοκτήτης που ασθενεί αποτελείτην πηγή της μόλυνσης.

Θα πρέπει επίσης να μη λησμονείται ότι οι υπηρεσίες δημόσιας υγείας σε όλο τον κόσμο, που ελέγχουν τη διασπορά του SARS-CoV-2, δήλωσαν ξανά κατηγορηματικά την τελευταία αυτή εβδομάδα ότι δεν υπάρχει καμία ένδειξη μετάδοσης από ζώα στον άνθρωπο. Εντούτοις, όπως συνιστάται στην Οδηγία μας, άτομα που πάσχουν από COVID-19 πρέπει να ελαχιστοποιούν τις άμεσες επαφές με τα ζώα τους για να αποφύγουν πιθανή μετάδοση της νόσου σε αυτά..

Η Αμερικανική Κτηνιατρική Εταιρεία [American Veterinary Medical Association (AVMA)] και το Κέντρο Ελέγχου των Ασθενειών [Centre for Disease Control (CDC)] εξέδωσαν περί το τέλος της τρέχουσας εβδομάδας «Ενδιάμεσες συστάσεις για τη διαχείριση των ζώων συντροφιάς από νοικοκυριά όπου διαβιούν άνθρωποι με COVID-19». Στο κείμενο αυτό περιλαμβάνεται υπενθύμιση να περιορίζονται, αν είναι δυνατόν στο σπίτι, ζώα με SARS-CoV-2. Αναφέρεται επίσης ότι το λούσιμο δεν είναι απαραίτητο και ότι υγιή ζώα που έχουν εκτεθεί στον ιό πρέπει να διατηρούνται σε ελάχιστη επαφή με άλλους (ζώα και ανθρώπους) επί 14 ημέρες, ενώ παράλληλα συγκεντρώνονται πρόσθετες πληροφορίες σχετικά με τη συχνότητα και τη διάρκεια της φυσικής μόλυνσης στις γάτες .

wsava webinar


Ένα διαδικτυακό σεμινάριο στο αντικείμενο αυτό πραγματοποιήθηκε στις 2 Απριλίου, στο οποίο συμμετείχα ως εκπρόσωπος της Παγκόσμιας Κτηνιατρικής Εταιρείας Μικρών Ζώων και του Πανεπιστημίου του Κολοράντο των ΗΠΑ, μαζί με τον Jim Tedford, Πρόεδρο και Διευθύνοντα Σύμβουλο του Οργανισμού Προώθησης Ευζωίας των Ζώων και την Δρ. Julie Levy από το Πανεπιστήμιο της Φλόριντα των ΗΠΑ. Η Δρ. Levy συμμετέχει ενεργά στην Οργάνωση Κτηνιάτρων Καταφυγίων των ΗΠΑ, η οποία συνεργάστηκε στενά με το CDC και την AVMA στη σύνταξη των συστάσεων.

Παρακολουθήστε το διαδικτυακό σεμινάριο εδώ

us order


Στις ΗΠΑ οι περισσότερες ρυθμιστικές υπηρεσίες ανακοίνωσαν χαλάρωση των τηλεϊατρικών περιορισμών για να συνδράμουν τους κτηνιάτρους να βοηθήσουν τα ζώα συντροφιάς, διατηρώντας παράλληλα τις κοινωνικές αποστάσεις για τα περιστατικά ρουτίνας. Η ανακοίνωση για τους κτηνιάτρους του Κολοράντο, βγήκε μόλις χθες. Ελπίζουμε και άλλες πολιτείες να ακολουθήσουν το παράδειγμα αυτό..

Διαβάστε την πλήρη ανακοίνωση εδώ

Αυτές ήταν οι βασικές εξελίξεις της εβδομάδας, γι’ αυτό κλείνοντας θα ήθελα να σας υπενθυμίσω, αν δεν το έχετε ήδη κάνει, να επισκεφθείτε ξανά τον ειδικό μας ιστότοπο WSAVA’s COVID-19 resource hub καθώς την εβδομάδα που μας πέρασε προσθέσαμε περιεχόμενο σε νέες γλώσσες. Στο σημείο αυτό θέλω να ευχαριστήσω για την εξαιρετική της δουλειά την Επιτροπή Μεταφράσεων,η οποία μεταφράζει κείμενα νυχθημερόν για να είναι διαθέσιμα για το δυνατόν περισσότερα μέλη μας.

Σας ευχαριστούμε όλους, για τη φροντίδα που παρέχετε στους ασθενείς σας και την ενημέρωση των ιδιοκτητών τους. Στους δύσκολους αυτούς καιρούς που διανύουμε, σας παρακαλούμε να κάνετε ό,τι είναι δυνατόν για να είστε ασφαλείς τόσο εσείς όσο και οι οικογένειές σας.

Michael R. Lappin, DVM, PhD, DACVIM (Internal Medicine)
The Kenneth W. Smith Professor in Small Animal Clinical Medicine, Colorado State University
Chairman, WSAVA One Health Committee

Visit the WSAVA COVID-19 resource hub here

 

 

WSAVA - COVID 19 - Ενημέρωση 27 Μαρτίου 2020

Γράφτηκε από τον/την ΕΛ.Ε.Κ.Ζ.Σ. στις .

wsavalogo

COVID-19 - An update for WSAVA Members
Week ending March 27, 2020

We recognize the additional strain that the COVID-19 pandemic is putting on our members and hope that this e-shot will be helpful in updating you on new developments and highlighting useful information.

The COVID-19 emergency gives us, as veterinarians and as a global community, a unique responsibility to uphold animal welfare and to support our medical colleagues. Let’s work together to share our knowledge and skills for the betterment of both human and animal health.

Dear Member Representatives

We are living through an extraordinary event impacting the lives of people and their pets globally. In many countries across the world, life is changing daily as governments combat the COVID-19 pandemic. We recognized the potential impact on veterinary practices, pets and pet owners early on and our One Health, Scientific, Vaccination and Animal Wellness and Welfare Committees have been working hard to keep you informed via our Advisory and the creation of our COVID-19 Resource Hub – details below. We have also communicated with the media globally, reinforcing the message that there is no evidence that COVID-19 can be caught from our pets. Going forward we will also provide updates via e-shot when there is important news to share.

This week, a key issue faced by our members has been achieving recognition that our services fall into the category of essential medical care. Colleagues around the world report that they are delivering only emergency care under protocols for client and pet access to veterinary premises. In countries under ‘lock down’ it is vital that veterinary practices remain accessible for urgent medical care and we have joined other veterinary bodies in calling for governmental recognition of the essential service that we provide.

The science of COVID-19 progresses with the publication of papers describing the virus and its receptor and hypothesizing on the likely animal origin of SARS-COV-2 into the human population. In Hong Kong, where pets belonging to owners diagnosed with COVID-19 have been precautionarily quarantined, information has been released on the second dog diagnosed as positive after contact with an infected human owner. In an excellent response by Professor Malik Peiris, Chair in Virology, Hong Kong University, it has become clear that the second dog has also now tested negative for the virus by PCR. Professor Peiris has emphasized that although these two dogs might have been infected by the virus, neither had COVID- 19 disease or was clinically ill. Professor Peiris has re-iterated the advice given previously that there is currently no evidence that dogs can transmit the virus to other dogs or to humans.

In response to questions from many of our colleagues, the Vaccination Guidelines Group has released a document giving advice the implications of not being able to access routine vaccination.

For colleagues in Brazil, where there has been confusion over the canine enteric coronavirus vaccine, Co-chair of our Scientific Committee and VGG member, Professor Mary Marcondes, has produced a short video in Portuguese, explaining the differences between coronaviruses and why it is inappropriate to consider that the enteric coronavirus vaccine might be relevant to SARS-COV-2.

Both of these resources are available in the COVID-19 Resource Hub.

To end on a positive note, this week has also seen stories emerging of the veterinary profession co-ordinating the transfer of ventilators from veterinary to human hospitals to increase their capacity to deal with COVID-19 patients. This heart-warming response is an excellent example of the One Health philosophy that is so strongly supported by WSAVA.

I would like to thank my colleagues for their hard work in preparing the Advisory and COVID-19 Resource Hub and we hope they are useful to you in these challenging times.

Emeritus Professor Michael J. Day
Chairman, WSAVA Vaccination Guidelines Group
Executive Board Liaison, WSAVA One Health Committee
WSAVA Honorary Treasurer

 

STOP PRESS

The WSAVA One Health and Scientific Committees are collecting more information about the cat in Belgium living with a person with COVID-19 that was reported to be RT-PCR positive and clinically ill. Please look out for a more detailed update on this next week. To date, we confirm that there is still no information proving that SARS-CoV-2 infection in a dog or cat can be passed on to other animals or to humans.

 

COVID-19 - Resources to help you

Advice and educational content are available to download in a variety of languages Our COVID-19 resource hub contains a wealth of resources to help you and your clients. We encourage you to check back often because we are updating it regularly.

Visit the WSAVA COVID-19 resource hub here

 

COVID-19- Share your story
We want to know how it is affecting your practice

If you have a COVID-19 story you’d like to share – perhaps an example of One Health in action or of how your practice is adapting to the crisis - or if you’d like to explain how the virus is affecting veterinary practice in your country, please tell us.

Please contact Αυτή η διεύθυνση ηλεκτρονικού ταχυδρομείου προστατεύεται από τους αυτοματισμούς αποστολέων ανεπιθύμητων μηνυμάτων. Χρειάζεται να ενεργοποιήσετε τη JavaScript για να μπορέσετε να τη δείτε. with your story.

 

On behalf of the WSAVA Secretariat,

Emma van Rooijen
Executive Assistant

World Small Animal Veterinary Association
t: +447897975363
e: Αυτή η διεύθυνση ηλεκτρονικού ταχυδρομείου προστατεύεται από τους αυτοματισμούς αποστολέων ανεπιθύμητων μηνυμάτων. Χρειάζεται να ενεργοποιήσετε τη JavaScript για να μπορέσετε να τη δείτε.
www.wsava.org

 

 

ΕΠΙΚΟΙΝΩΝΙΑ

Λουίζης Ριανκούρ 64 - Πύργος Απόλλων
Αμπελόκηποι - 115 23 Αθήνα

MB 0008 phone2107759727  Κιν.: 6945 311054 (WhatsApp & Viber)
 Επικοινωνία Δευτέρα - Παρασκευή 10.00-16.00

MB 0003 mail2Αυτή η διεύθυνση ηλεκτρονικού ταχυδρομείου προστατεύεται από τους αυτοματισμούς αποστολέων ανεπιθύμητων μηνυμάτων. Χρειάζεται να ενεργοποιήσετε τη JavaScript για να μπορέσετε να τη δείτε.


Visa  Mastercard  Maestro           vbv    sc 62x34